MMWR: Morbidity and Mortality Weekly Report: Surveillance Summaries, September 8, 2017 [open pdf - 272KB]
Alternate Title: BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 18-64 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas - United States, 2009-2014
"Genetic testing for breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2) gene mutations can identify women at increased risk for breast and ovarian cancer. These testing results can be used to select preventive interventions and guide treatment. Differences between nonmetropolitan and metropolitan populations in rates of BRCA testing and receipt of preventive interventions after testing have not previously been examined."
Morbidity and Mortality Weekly Report: http://www.cdc.gov/mmwr/index.html/
MMWR: Morbidity and Mortality Weekly Report (September 8, 2017), v.66 no.15